While there is currently no cure for Wagner syndrome, a variety of treatment options are available to manage its symptoms and prevent severe vision loss. The management of this condition is highly individualized, depending on the specific ocular manifestations present in each patient. The primary goal of treatment is to address complications as they arise and to preserve visual function for as long as possible.

Refractive errors, such as myopia, are common in Wagner syndrome and can typically be corrected with glasses or contact lenses. As patients often develop presenile cataracts—clouding of the lens at an unusually young age—cataract surgery is a frequent intervention. During this procedure, the cloudy lens is removed and replaced with an artificial intraocular lens (IOL), which can significantly improve visual clarity.

The most severe complication of Wagner syndrome is retinal detachment, which occurs when the retina is pulled away from its normal position due to abnormal traction from the degenerating vitreous. Retinal detachments require prompt surgical repair to prevent permanent blindness. Surgical options may include vitrectomy (removal of the vitreous gel), scleral buckling (placing a flexible band around the eye to counteract traction), or laser retinopexy to seal retinal tears. Due to the complex nature of the vitreo-retinal adhesions in Wagner syndrome, these surgeries can be challenging and should be performed by an experienced retina specialist.

Looking to the future, the therapeutic landscape for inherited retinal diseases is expanding. While specific pipeline treatments for Wagner syndrome are still in the preclinical stages, advancements in gene editing technologies, such as CRISPR, and novel drug delivery systems hold promise. Researchers are exploring ways to stabilize the vitreous structure or protect the retina from degeneration. Patients are encouraged to maintain regular check-ups with their healthcare provider to monitor their condition and to discuss any emerging therapies or clinical trials that may become available.